Novo Nordisk Expanding World's Largest Insulin Plant

GALWAY, IRELAND--April 8, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Denmark's pharmaceutical giant Novo Nordisk AS (NYSE:NVO) (Bagsvaerd, Denmark) is planning to spend almost DKK 650 million ($97.8 million) to upgrade and expand facilities at its main production site in Kalundborg, Denmark.

Within this article: Details new plant project and spend, products produced, related insulin news